메뉴 건너뛰기




Volumn 13, Issue 5, 2004, Pages 33-37

Clinical role of LDL and HDL subclasses and apolipoprotein measurement

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN; APOLIPOPROTEIN B; BIOCHEMICAL MARKER; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID;

EID: 3042814423     PISSN: 10621458     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.accreview.2004.04.095     Document Type: Review
Times cited : (18)

References (12)
  • 1
    • 85120233446 scopus 로고    scopus 로고
    • Blake GJ, Otvos JD, Rifai N, Ridker PM. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 2002;106:1930–7.
  • 2
    • 85120226243 scopus 로고    scopus 로고
    • Campos H, Moye LA, Glasser SP, Stampfer MJ, Sacks FM. Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA 2001;286:1468–74.
  • 3
    • 85120218047 scopus 로고    scopus 로고
    • Garvey WT, Kwon S, Zheng D, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003;52:453–62.
  • 4
    • 85120192522 scopus 로고    scopus 로고
    • Gotto AM Jr, Whitney E, Stein EA, et al. Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation 2000;101:477–84.
  • 5
    • 85120228430 scopus 로고    scopus 로고
    • Kuller L, Arnold A, Tracy R, et al. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 2002;22:1175–80.
  • 6
    • 85120235915 scopus 로고    scopus 로고
    • Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997;95:69–75.
  • 7
    • 85120209467 scopus 로고    scopus 로고
    • McKenney JM, McCormick LS, Schaefer EJ, Black DM, Watkins ML. Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia. Am J Cardiol 2001;88:270–4.
  • 8
    • 85120220910 scopus 로고    scopus 로고
    • Miller BD, Alderman EL, Haskell WL, Fair JM, Krauss RM. Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project. Circulation 1996;94:2146–53.
  • 9
    • 85120188628 scopus 로고    scopus 로고
    • Otvos JD, Shalaurova I, Freedman DS, Rosenson RS. Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial. Atherosclerosis 2002;160:41–8.
  • 10
    • 85120187478 scopus 로고    scopus 로고
    • Rosenson RS, Otvos JD, Freedman DS. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary arteries (PLAC-I) trial. Am J Cardiol 2002;90:89–94.
  • 11
    • 85120234039 scopus 로고    scopus 로고
    • St-Pierre AC, Ruel IL, Cantin B, et al. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 2001;104:2295–9.
  • 12
    • 85120230051 scopus 로고    scopus 로고
    • Zambon A, Hokanson JE, Brown BG, Brunzell JD. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation 1999;99:1959–64.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.